Cargando…
Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats
Objective: The present study explored whether levetiracetam (LEV) could protect against experimental brain ischemia and enhance angiogenesis in rats, and investigated the potential mechanisms in vivo and in vitro. Methods: The middle cerebral artery was occluded for 60 min to induce middle cerebral...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161206/ https://www.ncbi.nlm.nih.gov/pubmed/34054520 http://dx.doi.org/10.3389/fphar.2021.638209 |
_version_ | 1783700455625326592 |
---|---|
author | Yao, Xiang Yang, Wenping Ren, Zhendong Zhang, Haoran Shi, Dafa Li, Yanfei Yu, Ziyang Guo, Qiu Yang, Guangwei Gu, Yingjiang Zhao, Hairong Ren, Ke |
author_facet | Yao, Xiang Yang, Wenping Ren, Zhendong Zhang, Haoran Shi, Dafa Li, Yanfei Yu, Ziyang Guo, Qiu Yang, Guangwei Gu, Yingjiang Zhao, Hairong Ren, Ke |
author_sort | Yao, Xiang |
collection | PubMed |
description | Objective: The present study explored whether levetiracetam (LEV) could protect against experimental brain ischemia and enhance angiogenesis in rats, and investigated the potential mechanisms in vivo and in vitro. Methods: The middle cerebral artery was occluded for 60 min to induce middle cerebral artery occlusion (MCAO). The Morris water maze was used to measure cognitive ability. The rotation test was used to assess locomotor function. T2-weighted MRI was used to assess infarct volume. The neuronal cells in the cortex area were stained with cresyl purple. The anti-inflammatory effects of LEV on microglia were observed by immunohistochemistry. Enzyme-linked immunosorbent assays (ELISA) were used to measure the production of pro-inflammatory cytokines. Western blotting was used to detect the levels of heat shock protein 70 (HSP70), vascular endothelial growth factor (VEGF), and hypoxia-inducible factor-1α (HIF-1α) in extracts from the ischemic cortex. Flow cytometry was used to observe the effect of LEV on neuronal cell apoptosis. Results: LEV treatment significantly increased the density of the surviving neurons in the cerebral cortex and reduced the infarct size (17.8 ± 3.3% vs. 12.9 ± 1.4%, p < 0.01) after MCAO. Concurrently, the time required to reach the platform for LEV-treated rats was shorter than that in the saline group on day 11 after MCAO (p < 0.01). LEV treatment prolonged the rotarod retention time on day 14 after MCAO (84.5 ± 6.7 s vs. 59.1 ± 6.2 s on day 14 compared with the saline-treated groups, p < 0.01). It also suppressed the activation of microglia and inhibited TNF-α and Il-1β in the ischemic brain (135.6 ± 5.2 pg/ml vs. 255.3 ± 12.5 pg/ml, 18.5 ± 1.3 pg/ml vs. 38.9 ± 2.3 pg/ml on day 14 compared with the saline-treated groups, p < 0.01). LEV treatment resulted in a significant increase in HIF-1α, VEGF, and HSP70 levels in extracts from the ischemic cerebral cortex. At the same time, LEV reduced neuronal cell cytotoxicity and apoptosis induced by an ischemic stroke (p < 0.01). Conclusion: LEV treatment promoted angiogenesis and functional recovery after cerebral ischemia in rats. These effects seem to be mediated through anti-inflammatory and antiapoptotic activities, as well as inducing the expression of HSP70, VEGF, and HIF-1α. |
format | Online Article Text |
id | pubmed-8161206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81612062021-05-29 Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats Yao, Xiang Yang, Wenping Ren, Zhendong Zhang, Haoran Shi, Dafa Li, Yanfei Yu, Ziyang Guo, Qiu Yang, Guangwei Gu, Yingjiang Zhao, Hairong Ren, Ke Front Pharmacol Pharmacology Objective: The present study explored whether levetiracetam (LEV) could protect against experimental brain ischemia and enhance angiogenesis in rats, and investigated the potential mechanisms in vivo and in vitro. Methods: The middle cerebral artery was occluded for 60 min to induce middle cerebral artery occlusion (MCAO). The Morris water maze was used to measure cognitive ability. The rotation test was used to assess locomotor function. T2-weighted MRI was used to assess infarct volume. The neuronal cells in the cortex area were stained with cresyl purple. The anti-inflammatory effects of LEV on microglia were observed by immunohistochemistry. Enzyme-linked immunosorbent assays (ELISA) were used to measure the production of pro-inflammatory cytokines. Western blotting was used to detect the levels of heat shock protein 70 (HSP70), vascular endothelial growth factor (VEGF), and hypoxia-inducible factor-1α (HIF-1α) in extracts from the ischemic cortex. Flow cytometry was used to observe the effect of LEV on neuronal cell apoptosis. Results: LEV treatment significantly increased the density of the surviving neurons in the cerebral cortex and reduced the infarct size (17.8 ± 3.3% vs. 12.9 ± 1.4%, p < 0.01) after MCAO. Concurrently, the time required to reach the platform for LEV-treated rats was shorter than that in the saline group on day 11 after MCAO (p < 0.01). LEV treatment prolonged the rotarod retention time on day 14 after MCAO (84.5 ± 6.7 s vs. 59.1 ± 6.2 s on day 14 compared with the saline-treated groups, p < 0.01). It also suppressed the activation of microglia and inhibited TNF-α and Il-1β in the ischemic brain (135.6 ± 5.2 pg/ml vs. 255.3 ± 12.5 pg/ml, 18.5 ± 1.3 pg/ml vs. 38.9 ± 2.3 pg/ml on day 14 compared with the saline-treated groups, p < 0.01). LEV treatment resulted in a significant increase in HIF-1α, VEGF, and HSP70 levels in extracts from the ischemic cerebral cortex. At the same time, LEV reduced neuronal cell cytotoxicity and apoptosis induced by an ischemic stroke (p < 0.01). Conclusion: LEV treatment promoted angiogenesis and functional recovery after cerebral ischemia in rats. These effects seem to be mediated through anti-inflammatory and antiapoptotic activities, as well as inducing the expression of HSP70, VEGF, and HIF-1α. Frontiers Media S.A. 2021-05-14 /pmc/articles/PMC8161206/ /pubmed/34054520 http://dx.doi.org/10.3389/fphar.2021.638209 Text en Copyright © 2021 Yao, Yang, Ren, Zhang, Shi, Li, Yu, Guo, Yang, Gu, Zhao and Ren. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Yao, Xiang Yang, Wenping Ren, Zhendong Zhang, Haoran Shi, Dafa Li, Yanfei Yu, Ziyang Guo, Qiu Yang, Guangwei Gu, Yingjiang Zhao, Hairong Ren, Ke Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats |
title | Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats |
title_full | Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats |
title_fullStr | Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats |
title_full_unstemmed | Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats |
title_short | Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats |
title_sort | neuroprotective and angiogenesis effects of levetiracetam following ischemic stroke in rats |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161206/ https://www.ncbi.nlm.nih.gov/pubmed/34054520 http://dx.doi.org/10.3389/fphar.2021.638209 |
work_keys_str_mv | AT yaoxiang neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats AT yangwenping neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats AT renzhendong neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats AT zhanghaoran neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats AT shidafa neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats AT liyanfei neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats AT yuziyang neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats AT guoqiu neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats AT yangguangwei neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats AT guyingjiang neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats AT zhaohairong neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats AT renke neuroprotectiveandangiogenesiseffectsoflevetiracetamfollowingischemicstrokeinrats |